[HTML][HTML] Insulin-like growth factor (IGF) signaling in tumorigenesis and the development of cancer drug resistance

SK Denduluri, O Idowu, Z Wang, Z Liao, Z Yan… - Genes & diseases, 2015 - Elsevier
One of the greatest obstacles to current cancer treatment efforts is the development of drug
resistance by tumors. Despite recent advances in diagnostic practices and surgical …

[HTML][HTML] Androgen receptor signaling in prostate cancer development and progression

PE Lonergan, DJ Tindall - Journal of carcinogenesis, 2011 - ncbi.nlm.nih.gov
The androgen receptor (AR) signaling axis plays a critical role in the development, function
and homeostasis of the prostate. The classical action of AR is to regulate gene …

Cancer associated fibroblasts in cancer pathogenesis

OE Franco, AK Shaw, DW Strand… - Seminars in cell & …, 2010 - Elsevier
In the past century, gradual but sustained advances in our understanding of the molecular
mechanisms involved in the growth and invasive properties of cancer cells have led to better …

Insulin-like growth factor-I–dependent up-regulation of ZEB1 drives epithelial-to-mesenchymal transition in human prostate cancer cells

TR Graham, HE Zhau, VA Odero-Marah, AO Osunkoya… - Cancer research, 2008 - AACR
The epithelial-to-mesenchymal transition (EMT) is crucial for the migration and invasion of
many epithelial tumors, including prostate cancer. Although it is known that ZEB1 …

The androgen receptor in health and disease

T Matsumoto, M Sakari, M Okada… - Annual review of …, 2013 - annualreviews.org
Androgens play pivotal roles in the regulation of male development and physiological
processes, particularly in the male reproductive system. Most biological effects of androgens …

[HTML][HTML] Androgen receptor variants occur frequently in castration resistant prostate cancer metastases

X Zhang, C Morrissey, S Sun, M Ketchandji, PS Nelson… - PloS one, 2011 - journals.plos.org
Background Although androgens are depleted in castration resistant prostate cancer
(CRPC), metastases still express nuclear androgen receptor (AR) and androgen regulated …

Targeting the androgen receptor pathway in castration-resistant prostate cancer: progresses and prospects

R Ferraldeschi, J Welti, J Luo, G Attard, JS De Bono - Oncogene, 2015 - nature.com
Androgen receptor (AR) signaling is a critical pathway for prostate cancer cells, and
androgen-deprivation therapy (ADT) remains the principal treatment for patients with locally …

Evolution of androgen receptor targeted therapy for advanced prostate cancer

YNS Wong, R Ferraldeschi, G Attard… - Nature reviews Clinical …, 2014 - nature.com
The discovery of androgen dependence in prostate cancer in 1941 by Huggins and
colleagues has remained the backbone for the treatment of this disease. However, although …

Androgen action and metabolism in prostate cancer

SM Green, EA Mostaghel, PS Nelson - Molecular and cellular …, 2012 - Elsevier
The transcriptional programs regulated through the activity of the androgen receptor (AR)
modulate normal prostate development and the maintenance of prostatic functions at …

Castration-resistant prostate cancer: locking up the molecular escape routes

RM Attar, CH Takimoto, MM Gottardis - Clinical Cancer Research, 2009 - AACR
The understanding of the key role that androgens play on the normal and pathological
physiology of the prostate guided the development of different therapies for the treatment of …